These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8847658)

  • 1. Using severity rather than randomization for assignment in clinical trials: Monte Carlo tests and practical illustrations of the Robbins-Zhang method.
    Ross DC
    J Psychiatr Res; 1995; 29(4):315-32. PubMed ID: 8847658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival analysis with unreliable endpoints.
    Overall JE; Atlas RS
    J Psychiatr Res; 1997; 31(3):383-92. PubMed ID: 9306296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On model prespecification in confirmatory randomized studies.
    Edwards D
    Stat Med; 1999 Apr; 18(7):771-85. PubMed ID: 10327526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutoff assignment strategies for enhancing randomized clinical trials.
    Trochim WM; Cappelleri JC
    Control Clin Trials; 1992 Jun; 13(3):190-212. PubMed ID: 1320557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conditional Monte Carlo randomization tests for regression models.
    Parhat P; Rosenberger WF; Diao G
    Stat Med; 2014 Aug; 33(18):3078-88. PubMed ID: 24648378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethical and scientific features of cutoff-based designs of clinical trials: a simulation study.
    Cappelleri JC; Trochim WM
    Med Decis Making; 1995; 15(4):387-94. PubMed ID: 8544682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a combination drug with multiple doses in unbalanced factorial design clinical trials.
    Hung HM
    Stat Med; 2000 Aug; 19(16):2079-87. PubMed ID: 10931512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Choosing covariates in the analysis of clinical trials.
    Beach ML; Meier P
    Control Clin Trials; 1989 Dec; 10(4 Suppl):161S-175S. PubMed ID: 2605965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Permutation test following covariate-adaptive randomization in randomized controlled trials.
    Hasegawa T; Tango T
    J Biopharm Stat; 2009; 19(1):106-19. PubMed ID: 19127470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of data from group-randomized trials with repeat observations on the same groups.
    Murray DM; Hannan PJ; Wolfinger RD; Baker WL; Dwyer JH
    Stat Med; 1998 Jul; 17(14):1581-600. PubMed ID: 9699231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Directional baseline differences and type I error probabilities in randomized clinical trials.
    Overall JE; Magee KN
    J Biopharm Stat; 1992; 2(2):189-203. PubMed ID: 1300213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression Discontinuity Design: Simulation and Application in Two Cardiovascular Trials with Continuous Outcomes.
    van Leeuwen N; Lingsma HF; de Craen AJ; Nieboer D; Mooijaart SP; Richard E; Steyerberg EW
    Epidemiology; 2016 Jul; 27(4):503-11. PubMed ID: 27031038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generalized F test and generalized deviance test in two-way ANOVA models for randomized trials.
    Shen J; He X
    J Biopharm Stat; 2014; 24(3):523-34. PubMed ID: 24697334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing meta-regression methods for examining moderator relationships with dependent effect sizes: A Monte Carlo simulation.
    López-López JA; Van den Noortgate W; Tanner-Smith EE; Wilson SJ; Lipsey MW
    Res Synth Methods; 2017 Dec; 8(4):435-450. PubMed ID: 28556477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.
    Bustad A; Terziivanov D; Leary R; Port R; Schumitzky A; Jelliffe R
    Clin Pharmacokinet; 2006; 45(4):365-83. PubMed ID: 16584284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjusting for observational secondary treatments in estimating the effects of randomized treatments.
    Zhang M; Wang Y
    Biostatistics; 2013 Jul; 14(3):491-501. PubMed ID: 23349243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global tests for combination drug studies in factorial trials.
    Hung HM
    Stat Med; 1996 Feb; 15(3):233-47. PubMed ID: 8643882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the analysis of composite measures of quality in medical research.
    Moineddin R; Meaney C; Grunfeld E
    Stat Methods Med Res; 2017 Apr; 26(2):633-660. PubMed ID: 25296866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline correction in a two-way randomized blocks design.
    Overall JE; Magee KN
    J Biopharm Stat; 1992; 2(2):205-17. PubMed ID: 1300214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating long-term effects of treatment from placebo-controlled trials with an extension period, using virtual twins.
    Vittinghoff E; McCulloch CE; Woo C; Cummings SR
    Stat Med; 2010 May; 29(10):1127-36. PubMed ID: 20209478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.